I am a healthcare professional

Notice


Welcome to MEDICALLY. This website is a non-promotional international resource intended to facilitate transparent scientific exchange regarding developments in medical research and disease management. It is intended for healthcare professionals outside the United Kingdom (UK) and Australia. The content on this website may include scientific information about experimental or investigational compounds, indications and services that are not approved or valid in your jurisdiction. Registration status and prescribing information of medicinal products may differ between countries. Roche and Genentech do not support, endorse or recommend the unapproved use of any compound or service in your jurisdiction, including those discussed on this website.


Please refer to local product information for any medicinal products mentioned. Information available on this website does not constitute professional medical advice, and Roche and Genentech accept no responsibility for access to or use of the same. Healthcare professionals outside the US are required to register and log-in to access the full range of content available on this website.


By clicking on one of the healthcare professional buttons below, you acknowledge you have read and understood this message and that you are requesting access to MEDICALLY. If you are not a healthcare professional, please use the other links below to access information relevant to you.


Cookies


We use cookies on this site to enable the site to function properly and to enhance your user experience. Cookies are files stored in your browser, which most websites use to personalize your web experience. Your information will only be used to provide information that is relevant to you. It will not be used for any other purpose. If you wish to restrict or block cookies, which are set on your device, then you can do this through your browser settings.


You can find out more about cookies by browsing our Privacy Policy.

 

For healthcare professionals in Another Country browse medically.roche.com.

Not a healthcare professional? For individuals outside the US, browse Roche's patient website or roche.com. For individuals in the US, browse gene.com.

External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Leave site
Roche and Genentech at

Macula Society 2024

-
Coming soon
05:22 PM
Duration 7mins La Quinta Resort & Club, Palm Springs, California
Efficacy, Safety, and Durability of Faricimab▼ in Macular Edema Due to Retinal Vein Occlusion: 72-week Results From the Phase 3 BALATON and COMINO Trials
Kuriyan A, Abreu F, Arrisi P, Kotecha A, Liu Y, Retiere A, Willis J, Paris L

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
03:14 PM
Duration 7mins La Quinta Resort & Club, Palm Springs, California
Greater Volume Reduction of Hyperreflective Foci in DME With Faricimab▼ vs Aflibercept in Phase 3 YOSEMITE/RHINE
Chakravarthy U, Singh RP, Maunz A, Von Schulthess E, Patel K, Bachmeier I, Jones I, Cohen Y, Gibson K, Willis J, Glittenberg C, Fauser S

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
03:50 PM
Duration 7mins La Quinta Resort & Club, Palm Springs, California
Greater Reduction in Pigment Epithelial Detachment Size With Faricimab▼ vs Aflibercept During Head-to-Head Dosing in nAMD
Avery R, Lai T, Souverain A, Yang M, Willis J, Kotecha A, Patel S, Margaron P, Lim J, Khanani A

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
06:41 PM
Duration 7mins La Quinta Resort & Club, Palm Springs, California
Efficacy and Safety of Faricimab▼ in ALTIMETER: A Trial Exploring Biomarkers of Ang-2 Inhibition in Patients With DME
Vujosevic S, Amador M, Dieckmann A, Gibson K, Glittenberg C, Kotak A, Mar F, Souverain A, Titz B, Fawzi A

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
06:48 PM
Duration 7mins La Quinta Resort & Club, Palm Springs, California
Comparative Efficacy of Faricimab▼ for the Treatment of Diabetic Macular Edema (DME): A Systematic Literature Review (SLR) and Network Meta-Analysis (NMA)
Leng T, Holekamp N, Mar F, Gibson K, Paulo T, Buehrer C, Tabano D

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
06:55 PM
Duration 7mins La Quinta Resort & Club, Palm Springs, California
Impact of Faricimab▼ vs Aflibercept on Epiretinal Membrane Formation Over 2 Years in Eyes with DME in the YOSEMITE/RHINE Phase 3 Trials
Jaffe G, Ogura Y, Deak G, Gibson K, Schmidt-Erfurth U, Wang T, Westenskow P, Willis J

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
03:07 PM
Duration 7mins La Quinta Resort & Club, Palm Springs, California
Port Delivery System with Ranibizumab (PDS) Stabilizes Retinal Nonperfusion in Patients with Diabetic Macular Edema (DME) and Diabetic Retinopathy (DR): Results from Pagoda and Pavilion Phase 3 Trials
Gill M, Howard D, Menezes A, Rahman S, Latkany P

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
03:14 PM
Duration 7mins La Quinta Resort & Club, Palm Springs, California
The Return of PDS: Port Delivery System with Ranibizumab Is Back To Enable Continuous Delivery Of Anti-VEGF Therapy For Patients with nAMD, DME, and DR
de Juan E, Pieramici D, Campochiaro P, Chang M, Holekamp N, Gune S, Quezada Ruiz C, Wise G, Ranade S, Horvath J, Regillo C

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
03:21 PM
Duration 7mins La Quinta Resort & Club, Palm Springs, California
Extended Dosing of Faricimab▼ in the Phase 3 YOSEMITE/RHINE and TENAYA/LUCERNE Trials
Lim J, Singer M, Amador M, Hill L, Idowu O, Patel S, Yang M, Gibson K, Margaron P

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
03:35 PM
Duration 7mins La Quinta Resort & Club, Palm Springs, California
Real-World Clinical and Anatomical Outcomes in Patients With Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema Treated With Faricimab▼ in the United States: The FARETINA Study
Dedania V, Tabano D, Borkar D, Garmo V, Leng T, Shaia J, Kuo B, Myers R, LaPrise A, Ali F, Singh R

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar